People living with HIV on ART have accurate perception of lipodystrophy signs: A cross-sectional study

被引：14

作者：

Alencastro P.R. ^{[1
,2
]}

Barcellos N.T. ^{[2
]}

Wolff F.H. ^{[3
]}

Ikeda M.L.R. ^{[2
,4
]}

Schuelter-Trevisol F. ^{[4
]}

Brandão A.B.M. ^{[5
]}

Fuchs S.C. ^{[4
,6
]}

机构：

[1] Hospital Sanatório Partenon, State Department of Health, Rio Grande do Sul. Av. Bento Gonçalves, 3722, Porto Alegre, RS

[2] Post-graduate Program of Collective Health, Universidade Do Vale Do Rio Dos Sinos, Av. Unisinos, 950, São Leopoldo, RS

[3] Postgraduate Studies Program in Sciences in Gastroenterology and Hepatology, School of Medicine, Universidade Federal Do Rio Grande Do sul, R. Ramiro Barcelos 2600, Porto Alegre, RS

[4] Postgraduate Studies Program in Cardiology, School of Medicine, Universidade Federal Do Rio Grande Do sul, R. Ramiro Barcelos 2600, Porto Alegre, RS

[5] Post Graduate Studies Program in Medicine-Hepatology, Universidade Federal de Ciências da Saúde de Porto Alegre, R. Sarmento Leite, 245, Porto Alegre, RS

[6] Division of Cardiology, Centro de Pesquisa Clínica, 5o Andar, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcellos, 2350, Porto Alegre, RS

来源：

BMC Research Notes | / 10卷 / 1期

关键词：

AIDS; HIV; Lipoatrophy; Lipodystrophy; Lipohypertrophy;

D O I：

10.1186/s13104-017-2377-3

中图分类号：

学科分类号：

摘要：

Background: The prevalence of lipodystrophy ranges from 31 to 65%, depending on the criteria adopted for diagnosis. The usual methods applied in the diagnosis vary from self-perception, medical examination, skinfolds measurements, or even imaging assessment for confirmation of fat distribution changes. Although several methods have been developed, there is no gold standard for characterization of LA and LH, or mixed forms. This study aimed to compare self-reported signs of lipodystrophy with objective measures by skinfolds and circumferences, and to evaluate the prevalence of lipoatrophy (LA) and lipohypertrophy (LH) among subjects living with HIV/AIDS on ART. Methods: A cross-sectional study enrolled participants living with HIV/AIDS receiving ART, aged 18 years or older from an outpatient health care center, in Southern Brazil. Self-reported body fat enlargement in the abdomen, chest or breasts, and dorsocervical fat pad were used to determine LH, while LA was identified by self-reported fat wasting of the face, neck, legs, arms or buttocks. Measurements were obtained with a scientific caliper for infraorbital, buccal, and submandibular skinfolds, and using an inelastic tape to measure circumferences of waist, hip, neck, and arm. LH and LA were established by the presence of at least one self-reported sign. Results: Comparisons of self-reported signs with objective measurements for men and women were carried out in 815 participants on ART, out of 1240 participants with HIV infection. Self-report of decreased facial fat and sunken cheeks was associated with lower infraorbital, buccal, and submandibular skinfolds. Participants who reported buffalo hump had, on average, greater neck circumference, as well as those who have increased waist circumference also reported abdominal enlargement, but no buttock wasting. Men were most commonly affected by lipoatrophy (73 vs. 53%; P < 0.001), and women by lipohypertrophy (79 vs. 56%; P < 0.001). Conclusion: In conclusion, self-reported signs of lipodystrophy and lipoatrophy are prevalent, differ by gender, and are associated with objective measurements in people living with HIV/AIDS. © 2017 The Author(s).

引用

共 31 条

[21]

Carr A., Samaras K., Thorisdottir A., Kaufmann G.R., Chisholm D.J., Cooper D.A., Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study, Lancet, 353, pp. 2093-2099, (1999)

[22]

Tien P.C., Grunfeld C., What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection, Curr Opin Infect Dis, 17, pp. 27-32, (2004)

[23]

Alberti K.G., Zimmet P., Shaw J., The metabolic syndrome - A new worldwide definition, Lancet, 366, pp. 1059-1062, (2005)

[24]

Fields-Gardner C., HIV and AIDS, Nutrition Therapy and Pathophysiology, pp. 805-842, (2007)

[25]

Santos C.P., Felipe Y.X., Braga P.E., Ramos D., Lima R.O., Segurado A.C., Self-perception of body changes in persons living with HIV/AIDS: Prevalence and associated factors, AIDS, 19, pp. 14-21, (2005)

[26]

Iwuala S.O., Lesi O.A., Fasanmade O.A., Sabir A.A., Olamoyegun M.A., Okany C.C., Prevalence of and risk factors for lipoatrophy in patients with HIV infection in Nigeria, AIDS Res Treat, 2015, (2015)

[27]

Tien P.C., Benson C., Zolopa A.R., Sidney S., Osmond D., Grunfeld C., The study of fat redistribution and metabolic change in HIV infection (FRAM): Methods, design, and sample characteristics, Am J Epidemiol, 163, pp. 860-869, (2006)

[28]

Tien P.C., Cole S.R., Williams C.M., Li R., Justman J.E., Cohen M.H., Et al., Incidence of lipoatrophy and lipohypertrophy in the women's interagency HIV study, J Acquir Immune Defic Syndr, 34, pp. 461-466, (2003)

[29]

De Waal R., Cohen K., Maartens G., Systematic review of antiretroviral-associated lipodystrophy: Lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction, PLoS ONE, 8, (2013)

[30]

Finkelstein J.L., Gala P., Rochford R., Glesby M.J., Mehta S., HIV/AIDS and lipodystrophy: Implications for clinical management in resource-limited settings, J Int AIDS Soc, 18, (2015)

← 1 2 3 4 →